| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/(SICI)1096-9896(199611)180:3<243::AID-PATH655>3.0.CO;2-7 |
| P698 | PubMed publication ID | 8958799 |
| P2093 | author name string | Chen A | |
| Lee WH | |||
| Meng CL | |||
| Sheu LF | |||
| Ho KC | |||
| Chao CF | |||
| Leu FJ | |||
| P2860 | cites work | Epstein-barr virus-specific serodiagnostic tests in carcinomas of the head and neck | Q45797977 |
| Nasopharyngeal carcinoma in american children: Epstein-Barr virus-specific antibody titers and prognosis | Q45805318 | ||
| Human epithelial cell expression of an Epstein-Barr virus receptor | Q45835276 | ||
| The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. | Q45835618 | ||
| Association of Epstein-Barr virus with thymic carcinoma | Q45838821 | ||
| Epstein-Barr virus receptors on human pharyngeal epithelia | Q45840176 | ||
| Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. | Q45841044 | ||
| Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx | Q56689988 | ||
| Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. | Q34294106 | ||
| Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas | Q34323867 | ||
| Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma | Q34579494 | ||
| Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes | Q35019443 | ||
| Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx | Q35119129 | ||
| Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes | Q36047055 | ||
| Involucrin synthesis and tissue assembly by keratinocytes in natural and cultured human epithelia | Q36205307 | ||
| Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. | Q39493969 | ||
| Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas | Q41747775 | ||
| The oncogenic potential of Epstein-Barr virus nuclear antigen 1 in transgenic mice | Q43660830 | ||
| Structure of the Epstein-Barr virus nuclear antigen as probed with monoclonal antibodies | Q44623574 | ||
| Accurate identification of experimental pulmonary metastases | Q44879038 | ||
| Characterisation of eight monoclonal antibodies to involucrin | Q45189578 | ||
| Epstein-Barr virus gene expression in nasopharyngeal carcinoma | Q45205828 | ||
| P433 | issue | 3 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 243-248 | |
| P577 | publication date | 1996-11-01 | |
| P1433 | published in | Journal of Pathology | Q400296 |
| P1476 | title | Enhanced malignant progression of nasopharyngeal carcinoma cells mediated by the expression of Epstein-Barr nuclear antigen 1 in vivo | |
| P478 | volume | 180 |
| Q35665976 | Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses |
| Q37242266 | Clinical-translational approaches to the Nm23-H1 metastasis suppressor |
| Q27003831 | Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival |
| Q40547103 | Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells |
| Q38597231 | EBNA1. |
| Q33373662 | Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies |
| Q39582149 | Epstein-Barr virus contributes to the malignant phenotype and to apoptosis resistance in Burkitt's lymphoma cell line Akata. |
| Q40046633 | Epstein-Barr virus infection and nasopharyngeal carcinoma |
| Q40890211 | Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity |
| Q28082701 | Epstein-Barr virus latent genes |
| Q36099024 | Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model |
| Q40637962 | Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing |
| Q33718191 | Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration |
| Q40135893 | Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways |
| Q40258611 | Hepatitis C Virus E1 protein promotes cell migration and invasion by modulating cellular metastasis suppressor Nm23-H1. |
| Q42206678 | Modelling the structure of full-length Epstein-Barr virus nuclear antigen 1. |
| Q35841060 | Oncogenic gamma-herpesviruses: comparison of viral proteins involved in tumorigenesis |
| Q33863072 | Regulation of cell growth and death by Epstein-Barr virus |
| Q38246971 | Regulation of the metastasis suppressor Nm23-H1 by tumor viruses |
| Q57176933 | Role of Epstein-Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target |
| Q38166365 | The Epstein-Barr Virus EBNA1 Protein |
| Q38440804 | The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma |
| Q33656437 | Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes |
| Q26823898 | Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients |
| Q33809585 | Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta |
Search more.